TY - JOUR
T1 - Ecology of zoonoses
T2 - Natural and unnatural histories
AU - Karesh, William B.
AU - Dobson, Andrew P.
AU - Lloyd-Smith, James O.
AU - Lubroth, Juan
AU - Dixon, Matthew A.
AU - Bennett, Malcolm
AU - Aldrich, Stephen
AU - Harrington, Todd
AU - Formenty, Pierre
AU - Loh, Elizabeth H.
AU - MacHalaba, Catherine C.
AU - Thomas, Mathew Jason
AU - Heymann, David L.
N1 - Funding Information:
WBK, EL, and CM were funded by the US Agency for International Development (USAID) Emerging Pandemic Threats programme PREDICT. Support for economic assessments provided by SA and TH was provided by the Public Health Agency of Canada and the Canadian Ministry of Health. JOL-S is supported by US National Science Foundation grant EF-0928690 , the De Logi Chair in Biological Sciences, and the Research and Policy for Infectious Disease Dynamics programme of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. We thank James Newcomb, Robert Carlson, and Alex Thiermann for their input, and the anonymous reviewers for their detailed critiques and valuable suggestions. The contents are the responsibility of the authors and do not necessarily reflect the views of the governments of the USA, UK, or Canada.
PY - 2012/12
Y1 - 2012/12
N2 - More than 60% of human infectious diseases are caused by pathogens shared with wild or domestic animals. Zoonotic disease organisms include those that are endemic in human populations or enzootic in animal populations with frequent cross-species transmission to people. Some of these diseases have only emerged recently. Together, these organisms are responsible for a substantial burden of disease, with endemic and enzootic zoonoses causing about a billion cases of illness in people and millions of deaths every year. Emerging zoonoses are a growing threat to global health and have caused hundreds of billions of US dollars of economic damage in the past 20 years. We aimed to review how zoonotic diseases result from natural pathogen ecology, and how other circumstances, such as animal production, extraction of natural resources, and antimicrobial application change the dynamics of disease exposure to human beings. In view of present anthropogenic trends, a more effective approach to zoonotic disease prevention and control will require a broad view of medicine that emphasises evidence-based decision making and integrates ecological and evolutionary principles of animal, human, and environmental factors. This broad view is essential for the successful development of policies and practices that reduce probability of future zoonotic emergence, targeted surveillance and strategic prevention, and engagement of partners outside the medical community to help improve health outcomes and reduce disease threats.
AB - More than 60% of human infectious diseases are caused by pathogens shared with wild or domestic animals. Zoonotic disease organisms include those that are endemic in human populations or enzootic in animal populations with frequent cross-species transmission to people. Some of these diseases have only emerged recently. Together, these organisms are responsible for a substantial burden of disease, with endemic and enzootic zoonoses causing about a billion cases of illness in people and millions of deaths every year. Emerging zoonoses are a growing threat to global health and have caused hundreds of billions of US dollars of economic damage in the past 20 years. We aimed to review how zoonotic diseases result from natural pathogen ecology, and how other circumstances, such as animal production, extraction of natural resources, and antimicrobial application change the dynamics of disease exposure to human beings. In view of present anthropogenic trends, a more effective approach to zoonotic disease prevention and control will require a broad view of medicine that emphasises evidence-based decision making and integrates ecological and evolutionary principles of animal, human, and environmental factors. This broad view is essential for the successful development of policies and practices that reduce probability of future zoonotic emergence, targeted surveillance and strategic prevention, and engagement of partners outside the medical community to help improve health outcomes and reduce disease threats.
UR - http://www.scopus.com/inward/record.url?scp=84870261809&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870261809&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(12)61678-X
DO - 10.1016/S0140-6736(12)61678-X
M3 - Review article
C2 - 23200502
AN - SCOPUS:84870261809
SN - 0140-6736
VL - 380
SP - 1936
EP - 1945
JO - The Lancet
JF - The Lancet
IS - 9857
ER -